Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Alector, Inc.ALEC · Entity 6051 | Vice President, Finance | July 02, 2021 | July 07, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Alector, Inc.
Report date July 02, 2021 · Filed July 07, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 76,686 |
Ending reported balance
After 2021-07-06 transaction · row 9
9 source rows · reconciled sequenceRow 1 · 2021-07-02 · Exercise / conversion · Acquired 18,420 · Balance 145,106 Row 2 · 2021-07-02 · Exercise / conversion · Acquired 11,250 · Balance 156,356 Row 3 · 2021-07-02 · Exercise / conversion · Acquired 31,170 · Balance 187,526 Row 4 · 2021-07-02 · Sale · Disposed 90,840 · Balance 96,686 F1: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted August 31, 2020. Row 5 · 2021-07-02 · Sale · Disposed 20,000 · Balance 76,686 F1: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted August 31, 2020. F2: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $40.00 to $40.32 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. Row 6 · 2021-07-06 · Exercise / conversion · Acquired 1,042 · Balance 77,728 Row 7 · 2021-07-06 · Exercise / conversion · Acquired 625 · Balance 78,353 Row 8 · 2021-07-06 · Exercise / conversion · Acquired 1,667 · Balance 80,020 Row 9 · 2021-07-06 · Sale · Disposed 3,334 · Balance 76,686 F1: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted August 31, 2020. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.16 · Expires 2028-07-02 | Direct | 14,118 |
Reported balance
After 2021-07-02 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2021-07-02 · Exercise / conversion · Disposed 18,420 · Balance 14,118 F3: Shares subject to the option vest in 48 equal monthly installments beginning on August 2, 2018. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $10.14 · Expires 2028-11-06 | Direct | 10,625 |
Reported balance
After 2021-07-02 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2021-07-02 · Exercise / conversion · Disposed 11,250 · Balance 10,625 F4: One-fourth of the total number of shares subject to the option grant vested on November 1, 2019, and an additional 1/48th of the total number of shares vest monthly thereafter. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $17.15 · Expires 2029-11-06 | Direct | 48,830 |
Reported balance
After 2021-07-02 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2021-07-02 · Exercise / conversion · Disposed 31,170 · Balance 48,830 F5: Shares subject to the option vest in 48 equal monthly installments beginning on December 6, 2019. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.16 · Expires 2028-07-02 | Direct | 13,076 |
Reported balance
After 2021-07-06 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2021-07-06 · Exercise / conversion · Disposed 1,042 · Balance 13,076 F3: Shares subject to the option vest in 48 equal monthly installments beginning on August 2, 2018. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $10.14 · Expires 2028-11-06 | Direct | 10,000 |
Reported balance
After 2021-07-06 transaction · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · 2021-07-06 · Exercise / conversion · Disposed 625 · Balance 10,000 F4: One-fourth of the total number of shares subject to the option grant vested on November 1, 2019, and an additional 1/48th of the total number of shares vest monthly thereafter. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $17.15 · Expires 2029-11-06 | Direct | 47,163 |
Reported balance
After 2021-07-06 transaction · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · 2021-07-06 · Exercise / conversion · Disposed 1,667 · Balance 47,163 F5: Shares subject to the option vest in 48 equal monthly installments beginning on December 6, 2019. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted August 31, 2020.
F2: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $40.00 to $40.32 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
F3: Shares subject to the option vest in 48 equal monthly installments beginning on August 2, 2018.
F4: One-fourth of the total number of shares subject to the option grant vested on November 1, 2019, and an additional 1/48th of the total number of shares vest monthly thereafter.
F5: Shares subject to the option vest in 48 equal monthly installments beginning on December 6, 2019.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 06, 2021 Filed Jul 7, 2021 19:38 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,667 | $0.00 Strike: $17.15 | $0.00 |
DisclosureSEC source: 0001209191-21-045930 · doc4.xml · derivative · entry 15 Yu Calvin · CIK 0001757799 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,163 Underlying: Common Stock · 1,667 shares Expires 2029-11-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on December 6, 2019. Read SEC document |
| July 06, 2021 Filed Jul 7, 2021 19:38 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 625 | $0.00 Strike: $10.14 | $0.00 |
DisclosureSEC source: 0001209191-21-045930 · doc4.xml · derivative · entry 14 Yu Calvin · CIK 0001757799 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 625 shares Expires 2028-11-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: One-fourth of the total number of shares subject to the option grant vested on November 1, 2019, and an additional 1/48th of the total number of shares vest monthly thereafter. Read SEC document |
| July 06, 2021 Filed Jul 7, 2021 19:38 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,042 | $0.00 Strike: $8.16 | $0.00 |
DisclosureSEC source: 0001209191-21-045930 · doc4.xml · derivative · entry 13 Yu Calvin · CIK 0001757799 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,076 Underlying: Common Stock · 1,042 shares Expires 2028-07-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on August 2, 2018. Read SEC document |
| July 06, 2021 Filed Jul 7, 2021 19:38 UTC | Alector, Inc. ALEC · Entity 6051 | SaleCommon Stock | 3,334 | $34.65 | $115,523.10 |
DisclosureSEC source: 0001209191-21-045930 · doc4.xml · nonDerivative · entry 9 Yu Calvin · CIK 0001757799 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,686 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted August 31, 2020. Read SEC document |
| July 06, 2021 Filed Jul 7, 2021 19:38 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionCommon Stock | 1,667 | $17.15 | $28,589.05 |
DisclosureSEC source: 0001209191-21-045930 · doc4.xml · nonDerivative · entry 8 Yu Calvin · CIK 0001757799 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,020 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 06, 2021 Filed Jul 7, 2021 19:38 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionCommon Stock | 625 | $10.14 | $6,337.50 |
DisclosureSEC source: 0001209191-21-045930 · doc4.xml · nonDerivative · entry 7 Yu Calvin · CIK 0001757799 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,353 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 06, 2021 Filed Jul 7, 2021 19:38 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionCommon Stock | 1,042 | $8.16 | $8,502.72 |
DisclosureSEC source: 0001209191-21-045930 · doc4.xml · nonDerivative · entry 6 Yu Calvin · CIK 0001757799 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,728 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 02, 2021 Filed Jul 7, 2021 19:38 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 31,170 | $0.00 Strike: $17.15 | $0.00 |
DisclosureSEC source: 0001209191-21-045930 · doc4.xml · derivative · entry 12 Yu Calvin · CIK 0001757799 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,830 Underlying: Common Stock · 31,170 shares Expires 2029-11-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on December 6, 2019. Read SEC document |
| July 02, 2021 Filed Jul 7, 2021 19:38 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 11,250 | $0.00 Strike: $10.14 | $0.00 |
DisclosureSEC source: 0001209191-21-045930 · doc4.xml · derivative · entry 11 Yu Calvin · CIK 0001757799 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,625 Underlying: Common Stock · 11,250 shares Expires 2028-11-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: One-fourth of the total number of shares subject to the option grant vested on November 1, 2019, and an additional 1/48th of the total number of shares vest monthly thereafter. Read SEC document |
| July 02, 2021 Filed Jul 7, 2021 19:38 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 18,420 | $0.00 Strike: $8.16 | $0.00 |
DisclosureSEC source: 0001209191-21-045930 · doc4.xml · derivative · entry 10 Yu Calvin · CIK 0001757799 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,118 Underlying: Common Stock · 18,420 shares Expires 2028-07-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on August 2, 2018. Read SEC document |
| July 02, 2021 Filed Jul 7, 2021 19:38 UTC | Alector, Inc. ALEC · Entity 6051 | SaleCommon Stock | 20,000 | $40.02 | $800,320.00 |
DisclosureSEC source: 0001209191-21-045930 · doc4.xml · nonDerivative · entry 5 Yu Calvin · CIK 0001757799 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,686 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted August 31, 2020. F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $40.00 to $40.32 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| July 02, 2021 Filed Jul 7, 2021 19:38 UTC | Alector, Inc. ALEC · Entity 6051 | SaleCommon Stock | 90,840 | $31.14 | $2,828,757.60 |
DisclosureSEC source: 0001209191-21-045930 · doc4.xml · nonDerivative · entry 4 Yu Calvin · CIK 0001757799 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,686 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted August 31, 2020. Read SEC document |
| July 02, 2021 Filed Jul 7, 2021 19:38 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionCommon Stock | 31,170 | $17.15 | $534,565.50 |
DisclosureSEC source: 0001209191-21-045930 · doc4.xml · nonDerivative · entry 3 Yu Calvin · CIK 0001757799 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,526 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 02, 2021 Filed Jul 7, 2021 19:38 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionCommon Stock | 11,250 | $10.14 | $114,075.00 |
DisclosureSEC source: 0001209191-21-045930 · doc4.xml · nonDerivative · entry 2 Yu Calvin · CIK 0001757799 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,356 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 02, 2021 Filed Jul 7, 2021 19:38 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionCommon Stock | 18,420 | $8.16 | $150,307.20 |
DisclosureSEC source: 0001209191-21-045930 · doc4.xml · nonDerivative · entry 1 Yu Calvin · CIK 0001757799 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,106 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 02, 2021 Filed Jun 3, 2021 19:39 UTC | Alector, Inc. ALEC · Entity 6051 | SaleCommon Stock | 1,844 | $17.77 | $32,767.88 |
DisclosureSEC source: 0001209191-21-037942 · doc4.xml · nonDerivative · entry 1 Yu Calvin · CIK 0001757799 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,686 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. F2 · shares: The shares were acquired pursuant to the Issuer's 2019 Employee Stock Purchase Plan on May 28, 2021. Read SEC document |
| May 07, 2021 Filed May 11, 2021 18:48 UTC | Alector, Inc. ALEC · Entity 6051 | GrantCommon Stock | 16,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-031849 · doc4.xml · nonDerivative · entry 1 Yu Calvin · CIK 0001757799 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,686 F1 · shares: The reported shares are represented by performance share units, or PSUs. Fifty percent of the award will be earned if the Issuer's average closing stock price is $30 per share for 40 consecutive trading days and an additional fifty percent will be earned if the average closing stock price is $40 per share for 40 consecutive trading days. Upon attainment of the performance metrics, the shares vest in four equal quarterly installments beginning on the first vesting date as set forth in the PSU award agreement. Read SEC document |
| October 01, 2020 Filed Oct 5, 2020 16:31 UTC | Alector, Inc. ALEC · Entity 6051 | GrantStock Option (right to buy) · Derivative | 67,526 | $0.00 Strike: $10.24 | $0.00 |
DisclosureSEC source: 0001209191-20-053614 · doc4.xml · derivative · entry 1 Yu Calvin · CIK 0001757799 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,526 Underlying: Common Stock · 67,526 shares Expires 2030-09-30 F1 · derivative.exercise_date: One forty-eighth (1/48th) of the shares subject to the option shall vest on the one month anniversary of October 1, 2020 (the "Vesting Commencement Date"), and one forty-eighth (1/48th) of the shares shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month), subject to the Reporting Person continuing to be a service provider to the Issuer through each such date. Read SEC document |
| June 03, 2020 Filed Jun 5, 2020 16:40 UTC | Alector, Inc. ALEC · Entity 6051 | SaleCommon Stock | 300 | $32.02 | $9,606.00 |
DisclosureSEC source: 0001209191-20-034702 · doc4.xml · nonDerivative · entry 2 Yu Calvin · CIK 0001757799 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,686 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. Consists of 1,343 shares acquired on May 29, 2020 at a price of $15.8270 per share under the Issuer's 2019 Employee Stock Purchase Plan. F3 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $31.95 to $32.06 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| June 03, 2020 Filed Jun 5, 2020 16:40 UTC | Alector, Inc. ALEC · Entity 6051 | SaleCommon Stock | 1,043 | $31.04 | $32,374.72 |
DisclosureSEC source: 0001209191-20-034702 · doc4.xml · nonDerivative · entry 1 Yu Calvin · CIK 0001757799 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,986 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. Consists of 1,343 shares acquired on May 29, 2020 at a price of $15.8270 per share under the Issuer's 2019 Employee Stock Purchase Plan. F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $30.59 to $31.42 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| February 07, 2020 Filed Feb 10, 2020 16:42 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionStock Option (right to buy) · Derivative | 7,400 | $0.00 Strike: $10.14 | $0.00 |
DisclosureSEC source: 0001209191-20-007942 · doc4.xml · derivative · entry 10 Yu Calvin · CIK 0001757799 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,875 Underlying: Common Stock · 7,400 shares Expires 2028-11-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: One fourth (1/4th) of the shares subject to the option vested on November 1, 2019, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter. Read SEC document |
| February 07, 2020 Filed Feb 10, 2020 16:42 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionStock Option (right to buy) · Derivative | 2,825 | $0.00 Strike: $8.16 | $0.00 |
DisclosureSEC source: 0001209191-20-007942 · doc4.xml · derivative · entry 9 Yu Calvin · CIK 0001757799 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,538 Underlying: Common Stock · 2,825 shares Expires 2028-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: One forty-eighth (1/48th) of the shares subject to the option vested on August 2, 2018, and an additional one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter. Read SEC document |
| February 07, 2020 Filed Feb 10, 2020 16:42 UTC | Alector, Inc. ALEC · Entity 6051 | SaleCommon Stock | 24,033 | $35.02 | $841,635.66 |
DisclosureSEC source: 0001209191-20-007942 · doc4.xml · nonDerivative · entry 6 Yu Calvin · CIK 0001757799 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,686 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $35.00 to $35.13 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| February 07, 2020 Filed Feb 10, 2020 16:42 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionCommon Stock | 7,400 | $10.14 | $75,036.00 |
DisclosureSEC source: 0001209191-20-007942 · doc4.xml · nonDerivative · entry 5 Yu Calvin · CIK 0001757799 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,719 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 07, 2020 Filed Feb 10, 2020 16:42 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionCommon Stock | 2,825 | $8.16 | $23,052.00 |
DisclosureSEC source: 0001209191-20-007942 · doc4.xml · nonDerivative · entry 4 Yu Calvin · CIK 0001757799 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,319 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2020 Filed Feb 10, 2020 16:42 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionStock Option (right to buy) · Derivative | 725 | $0.00 Strike: $10.14 | $0.00 |
DisclosureSEC source: 0001209191-20-007942 · doc4.xml · derivative · entry 8 Yu Calvin · CIK 0001757799 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,275 Underlying: Common Stock · 725 shares Expires 2028-11-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: One fourth (1/4th) of the shares subject to the option vested on November 1, 2019, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter. Read SEC document |
| February 06, 2020 Filed Feb 10, 2020 16:42 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionStock Option (right to buy) · Derivative | 1,096 | $0.00 Strike: $8.16 | $0.00 |
DisclosureSEC source: 0001209191-20-007942 · doc4.xml · derivative · entry 7 Yu Calvin · CIK 0001757799 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,363 Underlying: Common Stock · 1,096 shares Expires 2028-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: One forty-eighth (1/48th) of the shares subject to the option vested on August 2, 2018, and an additional one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter. Read SEC document |
| February 06, 2020 Filed Feb 10, 2020 16:42 UTC | Alector, Inc. ALEC · Entity 6051 | SaleCommon Stock | 2,621 | $35.00 | $91,735.00 |
DisclosureSEC source: 0001209191-20-007942 · doc4.xml · nonDerivative · entry 3 Yu Calvin · CIK 0001757799 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,494 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| February 06, 2020 Filed Feb 10, 2020 16:42 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionCommon Stock | 725 | $10.14 | $7,351.50 |
DisclosureSEC source: 0001209191-20-007942 · doc4.xml · nonDerivative · entry 2 Yu Calvin · CIK 0001757799 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,115 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2020 Filed Feb 10, 2020 16:42 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionCommon Stock | 1,096 | $8.16 | $8,943.36 |
DisclosureSEC source: 0001209191-20-007942 · doc4.xml · nonDerivative · entry 1 Yu Calvin · CIK 0001757799 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,390 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 04, 2020 Filed Feb 6, 2020 17:18 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionStock Option (right to buy) · Derivative | 13,541 | $0.00 Strike: $8.16 | $0.00 |
DisclosureSEC source: 0001209191-20-007209 · doc4.xml · derivative · entry 3 Yu Calvin · CIK 0001757799 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,459 Underlying: Common Stock · 13,541 shares Expires 2028-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: One forty-eighth (1/48th) of the shares subject to the option vested on August 2, 2018, and an additional one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter. Read SEC document |
| February 04, 2020 Filed Feb 6, 2020 17:18 UTC | Alector, Inc. ALEC · Entity 6051 | SaleCommon Stock | 63,541 | $30.04 | $1,908,771.64 |
DisclosureSEC source: 0001209191-20-007209 · doc4.xml · nonDerivative · entry 2 Yu Calvin · CIK 0001757799 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,294 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $30.00 to $30.11 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| February 04, 2020 Filed Feb 6, 2020 17:18 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionCommon Stock | 13,541 | $8.16 | $110,494.56 |
DisclosureSEC source: 0001209191-20-007209 · doc4.xml · nonDerivative · entry 1 Yu Calvin · CIK 0001757799 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,835 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 03, 2019 Filed Dec 5, 2019 16:25 UTC | Alector, Inc. ALEC · Entity 6051 | SaleCommon Stock | 1,315 | $18.31 | $24,077.65 |
DisclosureSEC source: 0001209191-19-059299 · doc4.xml · nonDerivative · entry 1 Yu Calvin · CIK 0001757799 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,294 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. Consists of 1,315 shares acquired on November 29, 2019 at a price of $15.844 per share under the Issuer's 2019 Employee Stock Purchase Plan. Read SEC document |
| November 06, 2019 Filed Nov 8, 2019 16:31 UTC | Alector, Inc. ALEC · Entity 6051 | GrantStock Option (right to buy) · Derivative | 80,000 | $0.00 Strike: $17.15 | $0.00 |
DisclosureSEC source: 0001209191-19-055826 · doc4.xml · derivative · entry 1 Yu Calvin · CIK 0001757799 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2029-11-05 F1 · derivative.exercise_date: One forty-eighth (1/48th) of the shares subject to the option shall vest on the one month anniversary of November 6, 2019 (the "Vesting Commencement Date"), and one forty-eighth (1/48th) of the shares shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month), subject to the Reporting Person continuing to have a Service Relationship (as defined in the Issuer's 2019 Equity Incentive Plan) with the Issuer through each such date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.